Login
Login

User:Biochemistry&Love

{{quote box

| border=2px

| align=center

| bgcolor = Cornsilk

| title=Interesting Pharmacology Fact from the Wiki

| halign=center

| quote=The original formulation of 7 Up contained lithium citrate, the classic mood stabilizer drug used for treating bipolar disorder today.

}}

{{WikiProject Pharmacology topicon}}

{{WikiProject Medicine topicon}}

{{New page reviewer topicon}}

{{multiple image

| align = right

| direction = vertical

| width = 200

| caption_align = center

| header = Biochemistry Rorschach test

| image1 = 1zxn.jpg|thumb

| alt1 = Butterfly protein

| caption1 = Butterfly protein

| image2 = CaMKII.png

| alt2 = Circly-wircly

| caption2 = Circly-wircly

| image3 = P53.png

| alt3 = Magic doughnut

| caption3 = Magic doughnut

| image4 = Protein HMGCR PDB 1dq8.png

| alt4 = Rainbow ribbon

| caption4 = Rainbow ribbon

| image5 = Protein HDAC7A PDB 2nvr.png

| alt5 = Atomic wishbone

| caption5 = Atomic wishbone

| image6 = MonoamineOxidase-1GOS.png

| alt6 = Party shoes

| caption6 = Party shoes

}}

{{Yeoman Editor}}

=WikiProjects=

class="wikitable"

| {{User_Chemistry Project}}

| {{User_Drugs}}

| {{User MCB}}

{{User WPMed}}

| {{User AfC}}

| {{User WikiProject Law}}

{{Wikipedia:American Psychiatric Association/Userbox}}

| {{Wikipedia:The Wikipedia Library/Cochrane/Userbox}}

| {{Template:User WikiProject Women in Red}}

{{User Good Articles2|2}}

| {{Template:User DYK|17}}

| {{User Wikiversity}}

{{User wikipedia/New page reviewer}}

| {{user KC}}

| {{WikiProject Editor Retention Userbox2}}

[[WP:PHARM|WikiProject Pharmacology]]

{{Cquote|text=All things are poison, and nothing is without poison, the dosage alone makes it so a thing is not a poison.|author=Paracelsus}}

This is the WikiProject that most of my editing efforts have been dedicated towards. If you'd like to collaborate or would like my opinion about a pharmacology-related article, feel free to drop by my talk page and leave me a note. I'm always looking for pharmacology articles that could use some help!

{{Cquote|text=Always laugh when you can. It is cheap medicine.|author=Lord Byron}}

=Membership Status=

Activity status of members can be found here.

=Article Development=

Popular pages: Wikipedia:WikiProject Pharmacology/Popular pages. [https://tools.wmflabs.org/pageviews/ Pageviews] tool, for comparing pages and analysis over time.

===Department of Assessment===

{{Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality statistics}}

Guidelines: WP:PHARM/Assessment. [https://tools.wmflabs.org/enwp10/cgi-bin/list2.fcgi?run=yes&projecta=Pharmacology&importance=Unknown-Class&quality=Unassessed-Class Link] to the list of unassessed articles.

==Articles Assessed==

{{collapse|1=

{{Div col|colwidth=20em}}

  1. Abacavir/dolutegravir/lamivudine, 01:04, 29 April 2017 (UTC)
  2. Estrogen, 01:18, 29 April 2017 (UTC)
  3. Area under the curve (pharmacokinetics), 06:35, 29 April 2017 (UTC)
  4. Absorption (pharmacokinetics), 06:37, 29 April 2017 (UTC)
  5. Elimination (pharmacology), 06:39, 29 April 2017 (UTC)
  6. Liberation (pharmacology), 06:41, 29 April 2017 (UTC)
  7. Auxiliary label, 21:03, 1 May 2017‎ (UTC)
  8. Cefoxitin, 01:08, 9 May 2017 (UTC)
  9. Barrier isolator, 01:14, 9 May 2017 (UTC)
  10. Consultant pharmacist, 01:29, 9 May 2017 (UTC)
  11. Antidepressants and suicide risk, 01:40, 9 May 2017 (UTC)
  12. American Society of Health-System Pharmacists, 02:27, 11 May 2017 (UTC)
  13. Aspen Pharmacare, 02:30, 11 May 2017 (UTC)
  14. Boston Collaborative Drug Surveillance Program, 02:32, 11 May 2017 (UTC)
  15. Center for Drug Evaluation and Research, 02:36, 11 May 2017 (UTC)
  16. European Pharmaceutical Union, 02:38, 11 May 2017 (UTC)
  17. Generic Pharmaceutical Association, 02:39, 11 May 2017 (UTC)
  18. General Pharmaceutical Council, 02:44, 11 May 2017 (UTC)
  19. Generic Product Identifier, 02:48, 11 May 2017 (UTC)
  20. Cinacalcet, 02:54, 11 May 2017 (UTC)
  21. Etelcalcetide, 02:54, 11 May 2017 (UTC)
  22. DDAIP, 22:22, 11 May 2017 (UTC)
  23. Benoxathian, 22:23, 11 May 2017 (UTC)
  24. Adosopine, 22:25, 11 May 2017 (UTC)
  25. 18F-EF5, 22:36, 17 May 2017 (UTC)
  26. Albutoin, 22:25, 11 May 2017 (UTC)
  27. Alinidine, 22:25, 11 May 2017 (UTC)
  28. Aganirsen, 22:27, 11 May 2017 (UTC)
  29. Agaric acid, 22:30, 11 May 2017 (UTC)
  30. Aditoprim, 22:30, 11 May 2017 (UTC)
  31. Adibendan, 22:30, 11 May 2017 (UTC)
  32. Adarotene, 22:30, 11 May 2017 (UTC)
  33. Alrestatin, 22:39, 11 May 2017 (UTC)
  34. Disopyramide, 22:39, 11 May 2017 (UTC)
  35. Alisertib, 22:39, 11 May 2017 (UTC)
  36. Adozelesin, 22:39, 11 May 2017 (UTC)
  37. Aganodine, 22:39, 11 May 2017 (UTC)
  38. Adiphenine, 22:39, 11 May 2017 (UTC)
  39. Aluminium acetotartrate, 22:42, 11 May 2017 (UTC)
  40. Over-the-counter counseling, 13:43, 12 May 2017 (UTC)
  41. Trituration, 13:43, 12 May 2017 (UTC)
  42. Dental pharmacology, 22:08, 12 May 2017 (UTC)
  43. Desocodeine, 22:08, 12 May 2017 (UTC)
  44. Diarylquinoline, 22:22, 12 May 2017 (UTC)
  45. Extended-spectrum penicillin, 22:22, 12 May 2017 (UTC)
  46. Aminopenicillin, 22:22, 12 May 2017 (UTC)
  47. Carboxypenicillin, 22:22, 12 May 2017 (UTC)
  48. Ureidopenicillin, 22:22, 12 May 2017 (UTC)
  49. Monobactam, 22:22, 12 May 2017 (UTC)
  50. Β-Lactamase inhibitor, 22:22, 12 May 2017 (UTC)
  51. Colistin, 22:27, 12 May 2017 (UTC)
  52. Polymyxin, 22:27, 12 May 2017 (UTC)
  53. Carmoterol, 03:42, 13 May 2017 (UTC)
  54. Canertinib, 03:44, 13 May 2017 (UTC)
  55. Bafetinib, 04:25, 13 May 2017 (UTC)
  56. Almecillin, 04:25, 13 May 2017 (UTC)
  57. Acolbifene, 04:25, 13 May 2017 (UTC)
  58. Actaplanin, 04:25, 13 May 2017 (UTC)
  59. Anatabine, 04:25, 13 May 2017 (UTC)
  60. Arctiin, 04:25, 13 May 2017 (UTC)
  61. Aminocarb, 04:36, 13 May 2017 (UTC)
  62. Apricoxib, 04:36, 13 May 2017 (UTC)
  63. Ateronon, 04:36, 13 May 2017 (UTC)
  64. Arctigenin, 04:36, 13 May 2017 (UTC)
  65. Apalutamide, 04:36, 13 May 2017 (UTC)
  66. 4,16-Androstadien-3β-ol, 04:40, 13 May 2017 (UTC)
  67. 5-HT1D receptor agonist, 04:40, 13 May 2017 (UTC)
  68. 6β-Naltrexol, 04:40, 13 May 2017 (UTC)
  69. ADX-71149, 01:52, 15 May 2017 (UTC)
  70. Aldoxorubicin, 02:12, 15 May 2017 (UTC)
  71. Dipraglurant, 02:29, 15 May 2017 (UTC)
  72. Birabresib, 02:29, 15 May 2017 (UTC)
  73. Bornaprolol, 02:29, 15 May 2017 (UTC)
  74. Butidrine, 02:29, 15 May 2017 (UTC)
  75. Cinazepam, 02:29, 15 May 2017 (UTC)
  76. Cloprostenol, 02:29, 15 May 2017 (UTC)
  77. Salvage therapy, 17:03, 15 May 2017 (UTC)
  78. Beclabuvir, 18:01, 15 May 2017 (UTC)
  79. Pharmaceutical care, 18:28, 15 May 2017 (UTC)
  80. BMS-955176, 23:59, 15 May 2017 (UTC)
  81. Benorterone, 00:06, 16 May 2017 (UTC)
  82. Berefrine, 00:06, 16 May 2017 (UTC)
  83. Besifovir, 00:06, 16 May 2017 (UTC)
  84. Bardoxolone methyl, 00:11, 16 May 2017 (UTC)
  85. BGB-A317, 01:36, 17 May 2017 (UTC)
  86. BIT225, 01:36, 17 May 2017 (UTC)
  87. Benzamidenafil, 01:36, 17 May 2017 (UTC)
  88. Bradanicline, 01:36, 17 May 2017 (UTC)
  89. Brefonalol, 01:36, 17 May 2017 (UTC)
  90. Bufetolol, 01:36, 17 May 2017 (UTC)
  91. Bunitrolol, 01:44, 17 May 2017 (UTC)
  92. Butinoline, 01:44, 17 May 2017 (UTC)
  93. Cicloprolol, 01:44, 17 May 2017 (UTC)
  94. Cilag, 01:44, 17 May 2017 (UTC)
  95. Janssen-Cilag, 01:44, 17 May 2017 (UTC)
  96. Clocental, 22:17, 17 May 2017 (UTC)
  97. Clocinizine, 22:17, 17 May 2017 (UTC)
  98. Crisnatol, 22:17, 17 May 2017 (UTC)
  99. Cruex, 22:17, 17 May 2017 (UTC)
  100. DMBMPP, 22:17, 17 May 2017 (UTC)
  101. Domesticine, 22:17, 17 May 2017 (UTC)
  102. EGIS-7625, 22:17, 17 May 2017 (UTC)
  103. EVT-201, 22:17, 17 May 2017 (UTC)
  104. Eprobemide, 23:35, 17 May 2017 (UTC)
  105. Chemotactic drug-targeting, 23:40, 17 May 2017 (UTC)
  106. Cetamolol, 18:28, 20 May 2017 (UTC)
  107. Ciclafrine, 18:28, 20 May 2017 (UTC)
  108. Dithiazanine iodide, 18:28, 20 May 2017 (UTC)
  109. Droxinavir, 18:28, 20 May 2017 (UTC)
  110. Finrozole, 18:32, 20 May 2017 (UTC)
  111. Glasdegib, 18:32, 20 May 2017 (UTC)
  112. IP1867B, 18:32, 20 May 2017 (UTC)
  113. IMM-101, 18:32, 20 May 2017 (UTC)
  114. JNJ-26489112, 18:36, 20 May 2017 (UTC)
  115. JD5037, 18:36, 20 May 2017 (UTC)
  116. MK-2206, 18:36, 20 May 2017 (UTC)
  117. Morforex, 18:36, 20 May 2017 (UTC)
  118. PF-610355, 18:36, 20 May 2017 (UTC)
  119. PF-4840154, 18:36, 20 May 2017 (UTC)
  120. RG7795, 18:39, 20 May 2017 (UTC)
  121. RO4929097, 18:39, 20 May 2017 (UTC)
  122. WY-46824, 18:39, 20 May 2017 (UTC)
  123. ZK-93426, 18:39, 20 May 2017 (UTC)
  124. XJB-5-131, 18:40, 20 May 2017 (UTC)
  125. SB-200646, 18:42, 20 May 2017 (UTC)
  126. Alkyl-lysophospholipids, 23:52, 20 May 2017 (UTC)
  127. Celivarone, 23:57, 20 May 2017 (UTC)
  128. Closed system drug transfer device, 00:09, 21 May 2017 (UTC)
  129. Ellipta, 21:25, 21 May 2017 (UTC)
  130. Vilanterol, 21:25, 21 May 2017 (UTC)
  131. Fluticasone propionate, 21:25, 21 May 2017 (UTC)
  132. Entolimod, 21:25, 21 May 2017 (UTC)
  133. Enalaprilat, 21:25, 21 May 2017 (UTC)
  134. Enasidenib, 21:25, 21 May 2017 (UTC)
  135. Epostane, 21:25, 21 May 2017 (UTC)
  136. Etodroxizine, 21:25, 21 May 2017 (UTC)
  137. Filanesib, 21:25, 21 May 2017 (UTC)
  138. Fenisorex, 21:25, 21 May 2017 (UTC)
  139. Filibuvir, 21:25, 21 May 2017 (UTC)
  140. Fallypride, 21:42, 21 May 2017 (UTC)
  141. Fenethazine, 21:42, 21 May 2017 (UTC)
  142. Fidarestat, 21:42, 21 May 2017 (UTC)
  143. Fluroxene, 21:42, 21 May 2017 (UTC)
  144. Gepotidacin, 21:42, 21 May 2017 (UTC)
  145. Chidamide, 23:23, 22 May 2017 (UTC)
  146. Bucumolol, 23:23, 22 May 2017 (UTC)
  147. Midol, 23:23, 22 May 2017 (UTC)
  148. Cinnamedrine, 23:23, 22 May 2017 (UTC)
  149. Cliffside Malibu, 23:23, 22 May 2017 (UTC)
  150. Clorotepine, 23:23, 22 May 2017 (UTC)
  151. Dantron, 23:43, 22 May 2017 (UTC)
  152. Co-danthrusate, 23:43, 22 May 2017 (UTC)
  153. Coramsine, 23:43, 22 May 2017 (UTC)
  154. Dihydrochandonium, 23:43, 22 May 2017 (UTC)
  155. Dichloroisoprenaline, 23:46, 22 May 2017 (UTC)
  156. Cucurbitacin E, 23:46, 22 May 2017 (UTC)
  157. Delanterone, 00:11, 23 May 2017 (UTC)
  158. Diprafenone, 00:12, 23 May 2017 (UTC)
  159. Doravirine, 00:15, 23 May 2017 (UTC)
  160. Epelsiban, 00:15, 23 May 2017 (UTC)
  161. Ersentilide, 00:15, 23 May 2017 (UTC)
  162. Esuprone, 00:15, 23 May 2017 (UTC)
  163. Filorexant, 00:15, 23 May 2017 (UTC)
  164. Physicians' Desk Reference, 00:22, 23 May 2017 (UTC)
  165. Enramycin, 18:00, 24 May 2017 (UTC)
  166. Epristeride, 18:00, 24 May 2017 (UTC)
  167. Finafloxacin, 18:07, 24 May 2017 (UTC)
  168. Flucetorex, 18:07, 24 May 2017 (UTC)
  169. GRN-529, 18:19, 24 May 2017 (UTC)
  170. Galunisertib, 18:19, 24 May 2017 (UTC)
  171. Gluma, 18:19, 24 May 2017 (UTC)
  172. Hydromadinone, 18:19, 24 May 2017 (UTC)
  173. Hydroxyflutamide, 18:19, 24 May 2017 (UTC)
  174. Ipidacrine, 18:19, 24 May 2017 (UTC)
  175. Isocodeine, 18:25, 24 May 2017 (UTC)
  176. Ipragliflozin, 18:25, 24 May 2017 (UTC)
  177. Istiratumab, 18:25, 24 May 2017 (UTC)
  178. Larotrectinib, 18:25, 24 May 2017 (UTC)
  179. Licostinel, 18:25, 24 May 2017 (UTC)
  180. Linuron, 18:25, 24 May 2017 (UTC)
  181. Lorlatinib, 18:37, 24 May 2017 (UTC)
  182. Losoxantrone, 18:37, 24 May 2017 (UTC)
  183. Lugdunin, 18:37, 24 May 2017 (UTC)
  184. MDAT, 18:37, 24 May 2017 (UTC)
  185. Maduramicin, 18:37, 24 May 2017 (UTC)
  186. Mannomustine, 18:37, 24 May 2017 (UTC)
  187. Dimethyl fumarate, 01:37, 12 June 2017 (UTC)
  188. Econazole, 01:37, 12 June 2017 (UTC)
  189. Econazole/triamcinolone, 01:38, 12 June 2017 (UTC)
  190. Iodopindolol, 01:39, 12 June 2017 (UTC)
  191. History of pharmacy in the United States, 00:18, 5 July 2017 (UTC)
  192. Metabolism, 00:22, 5 July 2017 (UTC)
  193. Mometasone/formoterol, 00:25, 5 July 2017 (UTC)
  194. Motesanib, 00:27, 5 July 2017 (UTC)
  195. Naltalimide, 00:36, 5 July 2017 (UTC)
  196. Neboglamine, 00:36, 5 July 2017 (UTC)
  197. Orteronel, 00:36, 5 July 2017 (UTC)
  198. Oxibendazole, 00:36, 5 July 2017 (UTC)
  199. Oxifentorex, 00:36, 5 July 2017 (UTC)
  200. Pipoxizine, 00:36, 5 July 2017 (UTC)
  201. Piromelatine, 00:36, 5 July 2017 (UTC)
  202. Pituitrin, 00:36, 5 July 2017 (UTC)
  203. Joint Commission of Pharmacy Practitioners, 15:51, 9 July 2017 (UTC)
  204. Clinical pharmaceutical scientist, 15:51, 9 July 2017 (UTC)
  205. FMISO, 02:33, 10 July 2017 (UTC)
  206. Fluorocholine, 02:33, 10 July 2017 (UTC)
  207. Gandotinib, 02:33, 10 July 2017 (UTC)
  208. Ipatasertib, 02:33, 10 July 2017 (UTC)
  209. Savolitinib, 02:39, 10 July 2017 (UTC)
  210. Sapanisertib, 02:39, 10 July 2017 (UTC)
  211. Propoxate, 02:39, 10 July 2017 (UTC)
  212. Phenylbiguanide, 02:39, 10 July 2017 (UTC)
  213. PNU-142633, 02:39, 10 July 2017 (UTC)
  214. Grapefruit–drug interactions, 00:49, 19 July 2017 (UTC)
  215. Basmisanil, 00:56, 21 July 2017 (UTC)
  216. 5α-Dihydronorethisterone, 00:56, 21 July 2017 (UTC)
  217. Becampanel, 00:56, 21 July 2017 (UTC)
  218. BNN-20, 00:56, 21 July 2017 (UTC)
  219. BNN-27, 00:56, 21 July 2017 (UTC)
  220. Beta-Methylfentanyl, 00:56, 21 July 2017 (UTC)
  221. Candocuronium iodide, 00:56, 21 July 2017 (UTC)
  222. Desmethoxyfallypride, 00:56, 21 July 2017 (UTC)
  223. Diphenylcyclopropenone, 00:56, 21 July 2017 (UTC)
  224. Diquafosol, 00:56, 21 July 2017 (UTC)
  225. Methyltestosterone, 02:25, 26 July 2017 (UTC)
  226. Regrelor, 00:36, 4 August 2017 (UTC)
  227. Niflumic acid, 01:38, 29 September 2017 (UTC)
  228. ANAVEX2-73, 02:02, 29 September 2017 (UTC)
  229. Betamethasone benzoate, 04:56, 20 November 2017 (UTC)
  230. Betamethasone acetate, 04:56, 20 November 2017 (UTC)
  231. Betamethasone valerate, 04:56, 20 November 2017 (UTC)
  232. Betamethasone sodium phosphate, 04:56, 20 November 2017 (UTC)
  233. C-Met inhibitor, 04:56, 20 November 2017 (UTC)
  234. Diclazepam, 04:56, 20 November 2017 (UTC)
  235. Decernotinib, 04:56, 20 November 2017 (UTC)
  236. Dexamethasone acefurate, 04:56, 20 November 2017 (UTC)
  237. Dexamethasone acetate, 04:56, 20 November 2017 (UTC)
  238. Dexamethasone phosphate, 04:56, 20 November 2017 (UTC)
  239. Fenfluramine, 04:58, 20 November 2017 (UTC)
  240. Journal of Clinical Pharmacy and Therapeutics, 05:00, 20 November 2017 (UTC)
  241. Journal of Managed Care & Specialty Pharmacy, 05:00, 20 November 2017 (UTC)
  242. Journal of Pharmacy and Pharmaceutical Sciences, 05:00, 20 November 2017 (UTC)
  243. National Food and Drug Authority, 05:07, 20 November 2017 (UTC)
  244. Pharmaceutical industry in Nigeria, 05:07, 20 November 2017 (UTC)
  245. Pharmacists Council of Nigeria, 05:07, 20 November 2017 (UTC)
  246. Pharmacy and Poisons Board, 05:07, 20 November 2017 (UTC)
  247. GABAergic, 19:19, 25 November 2017 (UTC)
  248. Adenosinergic, 19:19, 25 November 2017 (UTC)
  249. Adrenergic, 19:19, 25 November 2017 (UTC)
  250. Cannabinoidergic, 19:19, 25 November 2017 (UTC)
  251. Cholinergic, 19:19, 25 November 2017 (UTC)
  252. Dopaminergic, 19:19, 25 November 2017 (UTC)
  253. Glycinergic, 19:19, 25 November 2017 (UTC)
  254. Histaminergic, 19:19, 25 November 2017 (UTC)
  255. Melatonergic, 19:19, 25 November 2017 (UTC)
  256. Monoaminergic, 19:19, 25 November 2017 (UTC)
  257. Serotonergic, 19:19, 25 November 2017 (UTC)
  258. Inactivated vaccine, 05:42, 23 February 2018 (UTC)
  259. Polio vaccine, 05:42, 23 February 2018 (UTC)
  260. Influenza vaccine, 05:42, 23 February 2018 (UTC)
  261. Comparison of bicalutamide with other antiandrogens, 17:57, 2 April 2018 (UTC)
  262. Medical uses of bicalutamide, 17:57, 2 April 2018 (UTC)
  263. Pharmacology of bicalutamide, 17:57, 2 April 2018 (UTC)
  264. Side effects of bicalutamide, 17:57, 2 April 2018 (UTC)
  265. DPT vaccine, 15:40, 14 July 2020 (UTC)
  266. Prestige Brands, 21:08, 15 July 2020 (UTC)

{{Div col end}}

|2=Articles assessed by datetime|bg=LightCyan

}}

WikiProject AfC

=Reviewing Articles=

List of articles pending review. Assessment scheme. Instructions for reviewing articles. Useful copyright infringement detector: [https://tools.wmflabs.org/copyvios/ Earwig's Copyvio Detector].

==Articles Reviewed==

{{Collapsible list

| expand =

| framestyle =border:10px dotted teal;

| titlestyle =

| title = List of reviewed articles with rationale and timedate

| liststyle =

| hlist =

| bullets =

|1. DRAFT:UC Riverside School of Public Policy, {{font color|red|declined}} for copyright infringement, 19:43, 14 May 2017. {{font color|red|{{font color|red|Deleted}}}} 19:47, 14 May 2017.

|2. DRAFT:Plant Based Foods Association, {{font color|red|declined}} for advertisement/self promotion. Notified submitter of WP:COI on their talk page. 20:34, 14 May 2017 (UTC)

|3. DRAFT:Duke Student Government, {{font color|red|declined}} for copyright infringement, 20:51, 14 May 2017. {{font color|red|{{font color|red|Deleted}}}} 21:46, 14 May 2017.

|4. DRAFT:Hydroelectric cell, {{font color|red|declined}} for inadequate reliable sources, 21:29, 15 May 2017 (UTC).

|5. DRAFT:Mount Zion College of Nursing, {{font color|red|declined}} for inadequate reliable sources, 21:49, 15 May 2017 (UTC).

|6. DRAFT:Ghana Society for Medical Physics (GSMP), {{font color|red|declined}} for copyright infringement, 22:24, 15 May 2017 (UTC). {{font color|red|Deleted}} 06:37, 16 May 2017.

|7. DRAFT:Fishman Uulenga, {{font color|red|declined}} BLP for lack of reliable sources to prove notability, 22:31, 15 May 2017 (UTC).

|8. DRAFT:Helena Dix, {{font color|red|declined}} BLP for lack of inline citations per WP:BLP, 22:37, 15 May 2017 (UTC).

|9. DRAFT:The Delta Riggs, {{font color|red|declined}} for lack of notability for a music group per WP:NMG, 23:01, 15 May 2017 (UTC).

|10. DRAFT:Thortspace, {{font color|red|declined}} for lack of notability, 23:13, 15 May 2017 (UTC).

|11. DRAFT:Kangpe, {{font color|red|declined}} for lack of notability, 23:21, 15 May 2017 (UTC).

|12. DRAFT:Trang Van Chinh, {{font color|red|declined}} for copyright infringement, 23:24, 15 May 2017 (UTC). {{font color|red|Deleted}} 16:47, 16 May 2017.

|13. DRAFT:Yali Saar, {{font color|red|declined}} for inadequate reliable sources. 23:40, 15 May 2017 (UTC).

|14. DRAFT:Ryan Swain, {{font color|red|declined}} BLP for lack of inline citations per WP:BLP, 23:48, 15 May 2017 (UTC).

|15. DRAFT:The XuanYuan Award, {{font color|red|declined}} for non-English language, 23:52, 15 May 2017 (UTC).

|16. DRAFT:PAR~A~DIGM, {{font color|red|declined}} for copyright infringement, 18:31, 16 May 2017 (UTC). Added to Wikipedia:Copyright problems/2017 May 16. {{font color|red|Deleted}} 21:10, 19 May 2017 (UTC).

|17. DRAFT:Business Centre Association (BCA), {{font color|red|declined}} for lack of notability for a company/organization, 22:49, 17 May 2017 (UTC).

|18. DRAFT:Lawrence McNally, {{font color|red|declined}} BLP for lack of notability, 22:57, 17 May 2017 (UTC).

|19. DRAFT:Gujarat Alkalies and Chemicals Limited, {{font color|red|declined}} for lack of notability for a company/organization, 23:04, 17 May 2017 (UTC).

|20. DRAFT:Treatment Methods for Mental Disorders, {{font color|red|declined}} for copyright infringement, 19:48, 21 May 2017 (UTC). {{font color|red|Deleted}} 03:04, 22 May 2017 (UTC).

|21. DRAFT:University of Oregon Special Collections & University Archives, {{font color|red|declined}} to be merged into Knight Library, for lack of notability, 19:52, 21 May 2017 (UTC).

|22. DRAFT:WISE Formula, {{font color|red|declined}} for lack of notability, 20:12, 21 May 2017 (UTC).

|23. DRAFT:Fei Xuan Zhou Huguet, {{font color|red|declined}} for lack of notability, 22:39, 22 May 2017 (UTC).

|24. DRAFT:Bombay Hemp Company, {{font color|red|declined}} per lack of inline citations for BLP content, per WP:BLP, 20:25, 21 May 2017 (UTC).

|25. DRAFT:Jean-Luc Allavena, {{font color|red|declined}} BLP per lack of inline citations, per WP:BLP, 20:40, 21 May 2017 (UTC).

|26. DRAFT:Krista Parris, {{font color|red|declined}} BLP per lack of notability, 20:50, 21 May 2017 (UTC).

|27. DRAFT:Eke U. Eke, {{font color|red|declined}} BLP for lack of reliable sources, noting possible WP:AB, 22:25, 22 May 2017 (UTC).

|28. DRAFT:Rajbhau Sontakke, {{font color|red|declined}} BLP per lack of notability, 22:27, 22 May 2017 (UTC).

|29. DRAFT:Cate Woodruff, {{font color|red|declined}} BLP for lack of inline citations, 22:29, 22 May 2017 (UTC).

|30. DRAFT:Charles Baumgardner, {{font color|red|declined}} on suspicion of hoax, 22:33, 22 May 2017 (UTC). {{font color|red|Deleted}} 10:17, 11 June 2017 (UTC).

|31. DRAFT:Tamara Dean, {{font color|red|declined}} BLP for lack of notability, 22:43, 22 May 2017 (UTC).

|32. DRAFT:Kamal Asgar, {{font color|red|declined}} for copyright infringement, 22:46, 22 May 2017 (UTC). {{font color|red|Deleted}} 04:04, 23 May 2017 (UTC).

|33. DRAFT:Running blades, {{font color|red|declined}} for essay tone, 22:50, 22 May 2017 (UTC).

|34. DRAFT:Elena Minor, possible copyright infringement, 23:01, 22 May 2017 (UTC). Added to Wikipedia:Copyright problems/2017 May 22.

|35. DRAFT:Rincón Bomba massacre, {{font color|red|declined}} for lack of reliable sources, 23:07, 22 May 2017 (UTC).

|36. DRAFT:Evolutive Progressive Intelligence, {{font color|red|declined}} for essay tone, 10:55, 23 May 2017 (UTC).

|37. DRAFT:DZFQ-FM, {{font color|red|declined}} for lack of independent sources, 11:02, 23 May 2017 (UTC).

|38. DRAFT:Stonewater, {{font color|red|declined}} for lack of notability, 22:53, 23 May 2017 (UTC).

|39. DRAFT:Joseph Ferriero, {{font color|red|declined}} for lack of notability, 23:03, 23 May 2017 (UTC).

|40. DRAFT:Martin Gerzabek, {{font color|red|declined}} for lack of notability, 23:14, 23 May 2017 (UTC).

|41. DRAFT:Dbx1, {{font color|red|declined}} for improper sourcing, per WP:PRIMARY, 23:19, 23 May 2017 (UTC).

|42. DRAFT:Pamela Price, {{font color|red|declined}} for lack of inline citations, 23:25, 23 May 2017 (UTC).

|43. DRAFT:Steve Balaban, {{font color|red|declined}} for lack of inline citations, 23:29, 23 May 2017 (UTC).

|44. DRAFT:Asim Ijaz Khwaja, {{font color|red|declined}} for lack of inline citations, 23:33, 23 May 2017 (UTC).

|45. DRAFT:Joe D'Orazio, {{font color|red|declined}} for lack of notability, 23:36, 23 May 2017 (UTC).

|46. DRAFT:James Holvay, {{font color|red|declined}} for lack of inline citations, 23:38, 23 May 2017 (UTC).

|47. DRAFT:Dass Babu, {{font color|red|declined}} for lack of reliable sources, 23:41, 23 May 2017 (UTC).

|48. DRAFT:Ali Chant, {{font color|red|declined}} BLP for lack of notability, 23:45, 23 May 2017 (UTC).

|49. DRAFT:Elective genetic and genomic testing, {{font color|red|declined}} for improper sourcing, 23:49, 23 May 2017 (UTC).

|50. DRAFT:Thetford Rugby Union Football Club, {{font color|red|declined}} rugby club (WP:NRU) for lack of notability, 00:05, 24 May 2017 (UTC).

|51. DRAFT:Nick Lamia, {{font color|red|declined}} BLP for lack on inline citations, 06:00, 25 May 2017 (UTC).

|52. DRAFT:Solomon Hailemariam, {{font color|red|declined}} BLP for lack on inline citations, 06:04, 25 May 2017 (UTC).

|53. DRAFT:Jessica Jackson Sloan, {{font color|red|declined}} BLP for lack on inline citations, 06:06, 25 May 2017 (UTC).

|54. DRAFT:Alberto Tovaglia, {{font color|red|declined}} BLP for lack of inline citations, 06:51, 25 May 2017 (UTC).

|55. DRAFT:St Mary's Anglican Church, Maitland, {{font color|red|declined}} for lack of notability, 06:56, 25 May 2017 (UTC).

|56. DRAFT:Jay Dunlap, {{font color|red|declined}} BLP for lack of inline citations, 06:59, 25 May 2017 (UTC).

|57. DRAFT:Clickfunding, {{font color|red|declined}} for lack of reliable sources, 16:48, 25 May 2017 (UTC).

|58. DRAFT:Simon Viklund, {{font color|red|declined}} BLP for lack of inline citations, 17:34, 25 May 2017 (UTC).

|59. DRAFT:Whitney Lynn, {{font color|red|declined}} BLP for lack of inline citations, 18:15, 29 May 2017 (UTC).

|60. DRAFT:GALA BAND, {{font color|red|declined}} for non-encyclopedic tone, 19:23, 10 June 2017 (UTC).

|61. DRAFT:JNTHN STEIN, {{font color|red|declined}} BLP for copyright infringement, 00:55, 13 June 2017 (UTC). {{font color|red|Deleted}} 02:18, 13 June 2017.

|62. DRAFT:Gay Bryant, {{font color|red|declined}} BLP for lack of inline citations, 01:00, 13 June 2017 (UTC).

|63. DRAFT:Washington Prodigy, {{font color|red|declined}} organization for lack of notability, 02:36, 15 June 2017 (UTC).

|64. DRAFT:Trumpeting Ecstasy, {{font color|red|declined}} album for lack of notability, 02:42, 15 June 2017 (UTC).

|65. DRAFT:CropZilla Software, Inc., {{font color|red|declined}} business for lack of notability, 02:56, 15 June 2017 (UTC).

|66. DRAFT:That's Mandarin, {{font color|red|declined}} business for lack of notability, 03:00, 15 June 2017 (UTC).

|67. DRAFT:ALICE Training, {{font color|red|declined}} for reading like an advertisement, 01:50, 16 June 2017 (UTC).

|68. DRAFT:Alice Eduardo, {{font color|red|declined}} BLP for lack of inline citations, 01:55, 16 June 2017 (UTC).

|69. DRAFT:Bijoux Burma, {{font color|red|declined}} for non-encyclopedic tone, 15:18, 17 June 2017 (UTC).

|70. DRAFT:Garrett Swanson, {{font color|red|declined}} BLP for lack of inline citations, 15:18, 17 June 2017 (UTC).

|71. DRAFT:Kristen Henry, {{font color|red|declined}} BLP for lack of notability, 15:18, 17 June 2017 (UTC).

|72. DRAFT:Peter Rohrman, {{font color|red|declined}} BLP for lack of notability, 15:40, 17 June 2017 (UTC).

|73. DRAFT:Remy Baggins, {{font color|red|declined}} BLP for lack of inline citations, 15:40, 17 June 2017 (UTC).

|74. DRAFT:Philip and Barry Castle, {{font color|red|declined}} for lack of proper sourcing, 15:44, 17 June 2017 (UTC).

|75. DRAFT:Jesse Cockney, {{font color|red|declined}} duplicate article, 16:45, 17 June 2017 (UTC).

|76. DRAFT:Gretchen Dow Simpson, {{font color|green|accepted}} with significant modification and moved to Gretchen Dow Simpson, 16:45, 17 June 2017 (UTC).

|77. DRAFT:Hippolytus Anthony Kunnunkal, commented, 06:30, 25 May 2017‎. Nominated CSD WP:G6 for copy-paste move; reverted, resolved on talk page. Nominated CSD WP:A7 (unremarkable person); reverted re: presumed notability per WP:NBISHOP and addition of new source, resolved on my talk page.

|78. DRAFT:Judy Burton, {{font color|green|accepted}} with significant modification and moved to Judy Burton, 23:49, 4 July 2017 (UTC).

|79. DRAFT:Supermicrosurgery, {{font color|red|declined}} for insufficient stand-alone content, and suggested merger with microsurgery, 00:09, 5 July 2017 (UTC).

|80. DRAFT:Dr James Best, {{font color|red|declined}} BLP for lack of notability, 21:55, 5 July 2017 (UTC).

|81. DRAFT:COS, {{font color|red|declined}} for sounding like an advertisement, 02:26, 10 July 2017 (UTC).

|82. DRAFT:Nick Lamia, {{font color|red|declined}} BLP for lack of inline citations, 22:46, 15 July 2017 (UTC).

|83. DRAFT:Elective genetic and genomic testing, {{font color|red|declined}} for lack of reliable sources (large quantities of uncited material), 02:38, 9 August 2017 (UTC).

|84. DRAFT:Wexner Israel Fellowship, {{font color|red|declined}} for lack of notability, 01:43, 27 October 2017 (UTC).

|85. DRAFT:Beyond The Trek, {{font color|red|declined}} for mostly being a plot summary, 03:23, 8 November 2017 (UTC).

|86. DRAFT:3Eleven Chicago, {{font color|red|declined}} for lack of notability, 03:27, 8 November 2017 (UTC).

|87. DRAFT:George Francis Donohue, {{font color|red|declined}} BLP for lack of inline citations, 03:29, 8 November 2017 (UTC).

|88. DRAFT:Barrister Abid Waheed Sheikh Draft 1, {{font color|red|declined}} BLP for lack of inline citations, 03:49, 8 November 2017 (UTC).

|89. DRAFT:Rudy Mawer, {{font color|red|declined}} BLP for (among other things) lack of inline citations, 03:49, 8 November 2017 (UTC).

|90. DRAFT:Mytona, {{font color|red|declined}} for lack of notability and non-English language, 03:49, 8 November 2017 (UTC).

}}

{{font color|Red|WikiProject Women in Red}}

Articles created for this project are tagged with the abbreviation: (Wikipedia:WikiProject Women in Red).

=World Contest 2017=

See page here. Entries are located here. Prize claims are here.

=Editing=

Below is the list of my current editing interests on Wikipedia. I would be happy to collaborate with others on scientific subjects in the field of biochemistry, molecular biology, pharmacology, and pharmacy practice.

Good articles

Information about good articles can be found here. Find nominations here.

=Contributions=

  1. Collaborative practice agreement, 13:45, 7 November 2017‎
  2. Rabeprazole, 22:56, 14 December 2017‎

=Reviews=

Nothing yet!

''Ab initio'' articles

This is a list of articles that I have written from the ground up, in the order that they have been approved/created.

1. Collaborative practice agreement {{classicon|GA}} (approved April 28, 2017), the first full-length article of mine that was approved!

:*Redirects added: Collaborative practice agreements, Consult agreement, Consult agreements, Collaborative pharmacy practice agreement, Collaborative pharmacy practice agreements, Physician-pharmacist agreement, Physician-pharmacist agreements, Standing protocol, Standing protocols, Physician delegation, Physician delegations

:*Disambiguation pages edited: Standing order, CPA

2. College of Psychiatric and Neurologic Pharmacists {{classicon|Start}} (approved April 29, 2017), the first full-length article that I wrote!

:*Redirects added: College of Psychiatric and Neurologic Pharmacy, College of Psychiatric and Neurological Pharmacists, College of Psychiatric and Neurological Pharmacy

:*Disambiguation pages created: CPNP

3. Coalition on Psychiatric Emergencies {{classicon|Start}} (approved April 30, 2017)

4. American College of Apothecaries (ACA) {{classicon|Start}} (approved May 2, 2017)

:*Disambiguation pages edited: ACA

5. American Association for Emergency Psychiatry (AAEP) {{classicon|Stub}} (approved June 13, 2017)

:*Disambiguation pages edited: AAEP

6. Joint Commission of Pharmacy Practitioners (JCPP) {{classicon|Start}} (approved July 8, 2017)

7. Clinical pharmaceutical scientist {{classicon|C}} (approved July 8, 2017)

:*Redirects added: Clinical pharmaceutical scientists, Pharmacist-scientist, Apothecary-scientist

8. Regrelor {{classicon|Start}} (approved August 3, 2017)

9. Elizabeth Marshall (pharmacist) {{classicon|Start}} (Wikipedia:WikiProject Women in Red) (approved November 6, 2017)

10. Mary Munson Runge {{classicon|Start}} (Wikipedia:WikiProject Women in Red) (approved November 7, 2017)

11. Metiapine {{classicon|Start}} (approved November 27, 2017)

12. Azeloprazole {{classicon|Start}} (approved December 26, 2017)

:*Redirects added: E3710, Z-215

13. Cerumenolytic {{classicon|Start}} (approved March 24, 2017)

:*Redirects added: Cerumenolytics, Ceruminolytic

14. Antipsychotic switching {{classicon|C}} (approved April 28, 2018)

15. Flumezapine {{classicon|C}} (approved June 11, 2018)

:*Redirects added: LY-120363

16. Pharmacist-to-pharmacy technician ratio {{classicon|Start|}} (approved July 1, 2018‎)

:*Redirects added: Pharmacist-to-technician ratio, Technician-to-pharmacist ratio, Pharmacy technician-to-pharmacist ratio

17. SEP-363856 {{classicon|Start|}} (approved June 21, 2019)

:*Redirects added: SEP-856

18. Appendicitis Inflammatory Response score {{classicon|Stub}} (approved August 15, 2020)

:*Redirects added: AIR score

Invigorated articles

Articles of which I did not start, but to which I contributed significantly:

  1. Psychiatric pharmacy {{classicon|stub}} → {{classicon|Start}}
  2. Over-the-counter counseling {{classicon|stub}} → {{classicon|Start}}
  3. Finafloxacin {{classicon|stub}} → {{classicon|C}}
  4. Clinafloxacin {{classicon|stub}} → {{classicon|C}}
  5. Rabeprazole {{classicon|Start}} → {{classicon|C}} → {{classicon|GA}}
  6. Zafirlukast {{classicon|stub}} → {{classicon|C}}
  7. Superficial vein thrombosis {{classicon|stub}} → {{classicon|B}}
  8. Interrupted aortic arch {{classicon|Start}} → {{classicon|C}}
  9. Cannabinoid hyperemesis syndrome {{classicon|Start}} → {{classicon|B}}
  10. Lofexidine {{classicon|Start}} →
  11. Setipiprant {{classicon|stub}} → {{classicon|Start}}
  12. Amiloride {{classicon|C}} →
  13. Fluticasone furoate/umeclidinium bromide/vilanterol {{classicon|stub}} → {{classicon|C}}
  14. Dopamine supersensitivity psychosis {{classicon|stub}} → {{classicon|Start}}

Did You Know

Rules are here. Submit nominations here. Find prep area and queue here. Find checklist for DYK reviews here.

=Promoted=

Did you know...

::Clinical pharmaceutical scientist 15px Displayed 7 August 2017. Stats [https://tools.wmflabs.org/pageviews/?project=en.wikipedia.org&platform=all-access&agent=user&start=2017-07-28&end=2017-08-07&pages=Clinical_pharmaceutical_scientist here]. Pageviews: 1733

::Over-the-counter counseling 15px Displayed 23 August 2017. Stats [https://tools.wmflabs.org/pageviews/?project=en.wikipedia.org&platform=all-access&agent=user&start=2017-08-13&end=2017-08-21&pages=Over-the-counter_counseling here]. Pageviews: 7512

{{main page image|image=RegrelorSpin.gif|caption= Chemical structure of Regrelor|width=120x133}}

::Regrelor 15px Displayed 24 August 2017. Stats [https://tools.wmflabs.org/pageviews/?project=en.wikipedia.org&platform=all-access&agent=user&start=2017-08-14&end=2017-08-22&pages=Regrelor here]. Pageviews: 5169

{{main page image|image=Finafloxacin.svg|caption=Chemical structure of finafloxacin|title=2D representation of finafloxacin's chemical structure|width=133}}

::Finafloxacin 15px Displayed 10 September 2017. Stats [https://tools.wmflabs.org/pageviews?start=2017-08-31&end=2017-09-20&project=en.wikipedia.org&pages=Finafloxacin here]. Pageviews: 4562

::Clinafloxacin 15px Displayed 29 September 2017. Stats [https://tools.wmflabs.org/pageviews/?project=en.wikipedia.org&platform=all-access&agent=user&start=2017-09-19&end=2017-09-30&pages=Clinafloxacin here]. Pageviews: 3005

::Mary Munson Runge 15px Displayed 4 December 2017. Stats [https://tools.wmflabs.org/pageviews?start=2017-11-24&end=2017-12-14&project=en.wikipedia.org&pages=Mary_Munson_Runge here]. Pageviews: 1966

::Elizabeth Marshall (pharmacist) 15px Displayed 5 December 2017. Stats [https://tools.wmflabs.org/pageviews?start=2017-11-25&end=2017-12-15&project=en.wikipedia.org&pages=Elizabeth_Marshall_(pharmacist) here]. Pageviews: 3138

::Collaborative practice agreement 15px Displayed 3 January 2018. Stats [https://tools.wmflabs.org/pageviews?start=2017-12-24&end=2018-01-13&project=en.wikipedia.org&pages=Collaborative_practice_agreement here]. Pageviews: 1764

::Zafirlukast 15px Displayed 7 January 2018. Stats [https://tools.wmflabs.org/pageviews?start=2017-12-28&end=2018-01-17&project=en.wikipedia.org&pages=Zafirlukast here]. Pageviews: 1520

::Azeloprazole 15px Displayed 18 January 2018. Stats [https://tools.wmflabs.org/pageviews?start=2018-01-08&end=2018-01-28&project=en.wikipedia.org&pages=Azeloprazole here]. Pageviews: 2512

{{main page image|image=Rabeprazolespin.gif|caption=3D representation of rabeprazole|width=120x133}}

:: Rabeprazole 15px Displayed 26 January 2018. Stats [https://tools.wmflabs.org/pageviews?start=2018-01-16&end=2018-02-05&project=en.wikipedia.org&pages=Rabeprazole here]. Pageviews: 15946

::Superficial vein thrombosis 15px Displayed 3 April 2018. Stats [https://tools.wmflabs.org/pageviews/?project=en.wikipedia.org&platform=all-access&agent=user&start=2018-04-01&end=2018-04-24&pages=Superficial_vein_thrombosis here]. Pageviews: 5405

::Cerumenolytic 15px Displayed 26 April 2018. Stats [https://tools.wmflabs.org/pageviews/?project=en.wikipedia.org&platform=all-access&agent=user&start=2018-04-01&end=2018-04-24&pages=Cerumenolytic here]. Pageviews: 3049

::Interrupted aortic arch 15px Displayed 6 May 2018. Stats [https://tools.wmflabs.org/pageviews/?project=en.wikipedia.org&platform=all-access&agent=user&range=latest-20&pages=Interrupted_aortic_arch here]. Pageviews: 1779

::Antipsychotic switching 15px Displayed 12 May 2018. Stats [https://tools.wmflabs.org/pageviews/?project=en.wikipedia.org&platform=all-access&agent=user&start=2018-05-02&end=2018-05-10&pages=Antipsychotic_switching here]. Pageviews: 1275

::Cannabinoid hyperemesis syndrome 15px Displayed 18 May 2018. Stats [https://tools.wmflabs.org/pageviews?start=2018-05-08&end=2018-05-28&project=en.wikipedia.org&pages=Cannabinoid_hyperemesis_syndrome here]. Pageviews: 14996

{{main page image|image=FLUMEZAPINESPINGIF.gif|caption=Flumezapine, spinning along its axis.|width=120x133}}

::Flumezapine 15px Displayed 24 June 2018. Stats [https://tools.wmflabs.org/pageviews?start=2018-06-14&end=2018-07-04&project=en.wikipedia.org&pages=Flumezapine here]. Pageviews: 1436

::Pharmacist-to-pharmacy technician ratio 15px Displayed 5 August 2018. Stats [https://tools.wmflabs.org/pageviews?start=2018-07-26&end=2018-08-15&project=en.wikipedia.org&pages=Pharmacist-to-pharmacy_technician_ratio here]. Pageviews: 1613

::SEP-363856 15px Displayed 9 August 2019. Stats [https://tools.wmflabs.org/pageviews?start=2019-07-30&end=2019-08-19&pages=SEP-363856 here]. Pageviews: 5556

::Fluticasone furoate/umeclidinium bromide/vilanterol 15px Displayed 6 August 2020. Stats [https://pageviews.toolforge.org/?project=en.wikipedia.org&platform=all-access&agent=user&redirects=0&start=2020-05-15&end=2020-08-13&pages=Fluticasone_furoate/umeclidinium_bromide/vilanterol here]. Pageviews: 1839

=Nominations=

  • None at the moment!

=Reviews=

  1. Microshaft Winblows 98 15px; using DYK credit for Elizabeth Marshall (pharmacist)
  2. Serious Hazards of Transfusion 15px, 15px; using DYK credit for Mary Munson Runge
  3. Plastic colorant 15px; using DYK credit for Collaborative practice agreement
  4. Blyth's kingfisher 15px, 15px; using DYK credit for Zafirlukast
  5. Fawad Khan 15px; using DYK credit for Rabeprazole
  6. Dominique Blake 15px; using DYK credit for Azeloprazole
  7. Westgate Tower 15px; using DYK credit for Superficial vein thrombosis
  8. Natalie Grams 15px, 15px; using DYK credit for Cerumenolytic
  9. Neil Swallow 15px, 15px; using DYK credit for Antipsychotic switching
  10. Sword Art Online 15px, 15px; using DYK credit for Interrupted aortic arch
  11. Transcriptomics technologies 15px, 15px; using DYK credit for Cannabinoid hyperemesis syndrome
  12. Alice Hutchison 15px; using DYK credit for Flumezapine
  13. Ralph Smith O’bré 15px, 15px; using DYK credit for Pharmacist-to-pharmacy technician ratio
  14. Lucy McBath 15px; using DYK credit for SEP-363856
  15. Li Zaiping 15px, 15px; using DYK credit for Fluticasone furoate/umeclidinium bromide/vilanterol
  16. Dee Booher 15px

New articles

=Works-in-progress=

To create new works-in-progress in Draft space, visit Wikipedia:Drafts. To submit the article for review, place {{tlf|subst:AFC submission/submit}} at the top of the article.

  • None

=Future projects=

Existing articles

=Current focus=

=Future projects=

=Milestones=